4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001387131-22-012236
Chief Executive Officer acquired 9,346,434 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DUGGAN ROBERT W Chief Executive Officer | 2022-12-06 | Other acquisition | +9,346,434 | 171,879,226 | D: show line 1 in the form |
Loading xslF345X03/duggan-form4_120622.xml…